Search company, investor...

Provox Technologies Corporation


Acquired | Acquired

Total Raised


About Provox Technologies Corporation

Provox Technologies Corporation is the leading producer of voice recognition documentation software for healthcare providers. TalkNotes interfaces with various practice management billing systems and creates an intuitive electronic medical chart.

Headquarters Location

2965 Colonnade Drive, SW Colonnade Corporate Center Suite 200

Roanoke, Virginia, 24018,

United States


Missing: Provox Technologies Corporation's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Provox Technologies Corporation's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Provox Technologies Corporation

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Provox Technologies Corporation is included in 1 Expert Collection, including Clinical Encounter Tech.


Clinical Encounter Tech

625 items

Latest Provox Technologies Corporation News

Investor Profile: Mid-Atlantic Venture Funds

Mar 23, 2013

Apple Glen Bressner from Mid-Atlantic Venture Funds is a member of FundingPost online! Venture Fund Member Profile Share This Profile: The Mid-Atlantic Venture Funds are four private venture capital partnerships (the first two were called NEPA Venture Funds) with approximately $200 million under management.Our primary investment interest is in purchasing the equity securities of new, young or growing businesses located in the Mid-Atlantic, although we can invest elsewhere, and have.Our investment capital has been provided by approximately 75 leading (mostly Mid-Atlantic-based) institutions and individuals. Nine principals of the general partners are either veteran venture capitalists or successful entrepreneurs. Glen Bressner Partner Mid-Atlantic Venture Funds Glen Bressner has been a partner with the Mid-Atlantic Venture Funds since its founding in 1985. The firm presently manages four venture capital partnerships and maintains offices in Bethlehem, PA, and Reston, Virginia. Upon completing his MBA, he began his career as a venture capitalist when he joined Key Venture Capital Corporation, a small business investment company, and opened its Boston office in 1984. He holds a BSBA, cum laude from Boston University and an MBA from Babson College. As Chairman of the Greater Philadelphia Venture Group in 1996-1997, Glen conceived and organized the first GPVG Venture Institute. He was responsible for MAVF investments in International Quantum Epitaxy (LSE: IQE plc), Innovative Solutions & Support (NASDAQ: ISSC), Access Health Marketing (NASDAQ: ACCS, acquired by HBO and Company), Axeda (NASDAQ: XEDA, formerly Ravisent Technologies, AnyTime Access (acquired by Digital Insight (NASDAQ: DGIN), UltraCision (acquired by Johnson & Johnson) and MicroE Systems. Representative Investments Provox Technologies Corporation Producer of voice recognition documentation software for healthcare providers. Provox's product, TalkNotes, interfaces with various practice management billing systems and creates an intuitive electronic medical chart. Storeroom Solutions Provides professional management of the maintenance, repair and operating supplies in the storerooms (spare parts rooms) of industrial plants. MicroE Systems Develops, manufactures and markets optical encoding technology for the precision positioning and measurement industries. CorePROFIT Solutions Simplifies the process of acquiring, calculating, interpreting and employing enterprise profitability information. Glen participated in the FundingPost event: PA Venture Capital Showcaseon Wed., May 7, 2008 in PA, Sponsored by Wolf Block To list your Company on our website and make your profile available to Glen and 7,500+ other VCs and Angel Investors, Click Here. About FundingPost For over Fourteen Years FundingPost has worked with thousandsof Angel and Venture Capital Investors. We believe that it isimportant to reach investors in every medium possible -both online and offline. We have been directly responsible fortons of success stories and Millions and Millions of dollars raised.We look forward to introducing your company to the leading Venture and Angel Investors nationwide. Sign up now: Entrepreneurs / Investors Join the FundingPost email list and learn how, when and where you can meet these Investors: Other Venture Profiles:

Provox Technologies Corporation Frequently Asked Questions (FAQ)

  • Where is Provox Technologies Corporation's headquarters?

    Provox Technologies Corporation's headquarters is located at 2965 Colonnade Drive, SW, Roanoke.

  • What is Provox Technologies Corporation's latest funding round?

    Provox Technologies Corporation's latest funding round is Acquired.

  • How much did Provox Technologies Corporation raise?

    Provox Technologies Corporation raised a total of $10.6M.

  • Who are the investors of Provox Technologies Corporation?

    Investors of Provox Technologies Corporation include Atirix Medical Systems, Gryphon Investors, Monument Capital Partners, MRW Capital, Mid-Atlantic Venture Funds and 6 more.

  • Who are Provox Technologies Corporation's competitors?

    Competitors of Provox Technologies Corporation include Implantable Provider Group, athenahealth, ArisGlobal, InstaMed, PHT Corporation and 9 more.

Compare Provox Technologies Corporation to Competitors

athenahealth Logo

athenahealth offers billing, practice management, and EHR services. athenahealth's offering is a web-based software, rules database offered as a subscription to physicians that combines in-office practice management functionality with a billing service. It is based in Watertown, Massachusetts.

Chiral Quest

Chiral Quest develops routes for intermediates and APIs and manages tech transfer to full-scale manufacturing. Chiral Quest aims to help its customers improve their operating efficiencies by: (1) shortening the time-line for production of complex APIs; (2) developing a scalable process that will provide increasing quantities as clinical trials advance; (3) managing an efficient and cost-effective supply chain for manufacture; (4) providing robust QC methods and a strong CMC package.


Endovasix is a developer of a proprietary technology used to treat acute cerebral arterial clots that cause strokes. Its initial offering is a technology that breaks apart an acute clot in a more effective fashion than thrombolytic drugs, and that can be used adjunctively with a wide array of interventional cardiology and radiology procedures. The target market includes Vascular Neurologists, Interventional Radiologists, NeuroRadiologists, and Cardiologists and Endovascular Surgeons and Neurosurgeons who treat patients who have experienced an occlusive stroke, coronary artery disease, or a peripheral stroke.

NCI Cancer Hospital

NCI Cancer Hospital is a private oncology centre in Malaysia that combines treatment and clinical research. NCI aims to provide a range of services from diagnosis, laboratory analysis, surgery, chemotherapy and radiotherapy. It operates to GCP and has conducted clinical trials for a number of pharmaceutical companies including Roche, BMS and AstraZeneca.

Nuvita Logo

Nuvita is a corporate wellness solution. Nuvita is designed to improve employee health and reduce costs.

PEP Systems

PEP Systems aims to help pharmacy owners track the payments to the prescriptions previously dispensed. PEP was developed in response to Medicare Part D which has increased the number of prescriptions being handled by third-party insurers.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.